Aranesp 10 Mikrogramm

Aranesp 10 Mikrogramm is a medicine authorised by Swissmedic under authorisation number 55725. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 September 2002 and the authorisation is valid without a time limit. ATC code B03XA02 places the medicine in the group Antianemic preparations.

  • Dispensing category A
  • Authorisation number 55725
  • ATC B03XA02
  • Biotechnological medicines
Authorisation data
Authorisation number55725
NameAranesp 10 Mikrogramm
Full nameAranesp 10 Mikrogramm, Injektionslösung in Fertigspritze
Authorisation holderAmgen Switzerland AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeB03XA02
First authorisation13 September 2002
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Aranesp 10 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
3Aranesp 20 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
4Aranesp 30 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
5Aranesp 40 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
6Aranesp 50 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
7Aranesp 60 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
8Aranesp 80 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
9Aranesp 100 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
10Aranesp 150 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
11Aranesp 300 Mikrogramm, Injektionslösung in FertigspritzeA13 September 2002
12Aranesp 500 Mikrogramm, Injektionslösung in FertigspritzeA17 April 2003

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
21Spritze(n)B03XA0206.07.3.A
44Spritze(n)B03XA0206.07.3.A
551Spritze(n)B03XA0206.07.3.A
564Spritze(n)B03XA0206.07.3.A
571Spritze(n)B03XA0206.07.3.A
584Spritze(n)B03XA0206.07.3.A
591Spritze(n)B03XA0206.07.3.A
604Spritze(n)B03XA0206.07.3.A
611Spritze(n)B03XA0206.07.3.A
624Spritze(n)B03XA0206.07.3.A
631Spritze(n)B03XA0206.07.3.A
644Spritze(n)B03XA0206.07.3.A
651Spritze(n)B03XA0206.07.3.A
664Spritze(n)B03XA0206.07.3.A
671Spritze(n)B03XA0206.07.3.A
684Spritze(n)B03XA0206.07.3.A
691Spritze(n)B03XA0206.07.3.A
704Spritze(n)B03XA0206.07.3.A
711Spritze(n)B03XA0206.07.3.A
731Spritze(n)B03XA0206.07.3.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Aranesp 10 Mikrogramm authorised in Switzerland?

Yes. Aranesp 10 Mikrogramm is authorised by Swissmedic under authorisation number 55725, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Aranesp 10 Mikrogramm have?

Aranesp 10 Mikrogramm is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Aranesp 10 Mikrogramm?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com